UBS downgrades Globe Telecom stock to Neutral on regulatory concerns

UBS has downgraded Philippine telecommunications firm Globe Telecom Inc. (GLO) from Buy to Neutral, lowering its price target to PHP1,650.00 from PHP2,300.00. This downgrade is driven by increased earnings risk stemming from the Konektadong Pinoy law and the Philippine administration’s crackdown on online gaming, which could negatively impact Globe’s digital wallet business. Despite a Q2 earnings rebound and attractive 8% free cash flow and 6% dividend yields, these regulatory concerns are expected to keep shares trading sideways until further clarity emerges.

Analysis

UBS has downgraded Globe Telecom Inc. (GLO) to Neutral from Buy and significantly reduced its price target to PHP1,650.00 from PHP2,300.00, citing mounting regulatory risks. The primary drivers for the downgrade are the anticipated negative earnings impact from the Konektadong Pinoy law and the potential disruption to its digital wallet business stemming from a government crackdown on online gaming. This negative outlook persists despite a reported second-quarter earnings rebound and has contributed to the stock's significant underperformance, with a 27% year-to-date decline compared to its competitor, PLDT. While Globe's substantial 8% free cash flow yield and 6% dividend yield are expected to provide a valuation floor, UBS projects the stock will trade sideways in the near term, awaiting crucial clarity from the final implementing rules and regulations of the new law.

Key Decisions for Investors

• Investors should consider a cautious or neutral stance on Globe Telecom, as the significant regulatory overhang is likely to cap near-term upside potential until there is definitive clarity on the Konektadong Pinoy law.
• For income-focused portfolios, the 8% free cash flow and 6% dividend yields offer strong support and income generation, but this must be weighed against the risk of capital erosion should the regulatory impact prove more severe than anticipated.
• Given the stock's 27% year-to-date underperformance and the expectation of range-bound trading, it may be prudent to await the resolution of regulatory uncertainties before committing new capital.